Does the FDA Save Lives? (with Peter Van Doren)
May 07, 2021•54 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
FDA reviewers have strong incentive to restrict access to new drugs and other therapies until there is extensive evidence that the therapies are safe. These incentives work against patients suffering painful or terminal diseases that have no effective therapy. And throughout the COVID-19 pandemic the FDA was continually in the spotlight for its poorly handling many potential COVID-19 remedies.
Why do we have an FDA?
Hosted on Acast. See acast.com/privacy for more information.
For the best experience, listen in Metacast app for iOS or Android